HIMS (Hims & Hers Health) Tariff Resilience Score: 6/10 (As of Jul. 01, 2026)


HIMS Hims & Hers Health Inc HIMS
81 GF Score
Price $37.74
GF Value $38.91
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health Tariff Resilience Score?

Hims & Hers Health HIMS +8.85% 81 Tariff Resilience Score is 6 as of Jul. 01, 2026. GuruFocus rates HIMS with a GF Score™ of 81/100 and a GF Value™ of $38.91 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,029 Drug Manufacturers companies, Hims & Hers Health ranks better than 91.16% on this metric.

Hims & Hers Health has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Hims & Hers Health has HIMS has moderate exposure to tariffs due to its reliance on imported products. However, its strong brand and pricing power provide some resilience, allowing it to pass on costs to consumers if necessary.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Hims & Hers Health might have Average Resilient.

Hims & Hers Health  (NYSE:HIMS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Hims & Hers Health Tariff Resilience Score Related Terms

HIMS vs LNTH, LQDA, ALKS: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hims & Hers Health's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hims & Hers Health Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hims & Hers Health's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Hims & Hers Health's Tariff Resilience Score falls into.


HIMS
81GF Score
Hims & Hers Health Inc HIMS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Hims & Hers Health (HIMS) has a Tariff Resilience Score of 6 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Hims & Hers Health ranks #91 out of 1029 companies in the Drug Manufacturers industry, placing it in the top 8.8%.
Is Hims & Hers Health's Tariff Resilience Score too high?
Hims & Hers Health's current Tariff Resilience Score is 6. Based on the distribution chart, Hims & Hers Health ranks #91 out of 1029 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hims & Hers Health has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Tariff Resilience Score compare to LNTH and LQDA?
According to the Drug Manufacturers industry distribution chart, Hims & Hers Health ranks #91 out of 1029 companies for Tariff Resilience Score. This places Hims & Hers Health in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Hims & Hers Health's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (HIMS) is currently considered Fairly Valued. The stock's GF Value™ is $38.91, compared to a current price of $37.74 — trading 3% below its estimated fair value. The current Tariff Resilience Score is 6. Hims & Hers Health's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Hims & Hers Health (HIMS), the current Tariff Resilience Score is 6 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of $37.74 is trading 3% below its estimated GF Value™ of $38.91. GuruFocus considers Hims & Hers Health to be Fairly Valued.

Key valuation signals for HIMS:

  • Tariff Resilience Score: 6
  • GF Value™: $38.91 vs. price of $37.74 (3% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Other Exchanges HIMS:Mexico82W:Germany
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
81GF Score

Get the complete analysis for HIMS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.74
Price
$38.91
GF Value